Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Subjects: | |
| Online Access: | https://doi.org/10.5281/zenodo.14715830 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- <p><span>This review explores Moringa oleifera tablets, focusing on novel formulation techniques to enhance bioavailability and improve patient compliance. Moringa oleifera, known for its phytochemical richness, is widely recognized for its therapeutic properties. Tablets offer a convenient dosage form, but challenges like poor bioavailability and limited clinical data hinder their widespread use. The review integrates phytochemical analyses, clinical studies, and advanced formulation research findings. Emphasis is placed on emerging trends, such as nanotechnology and AI-driven design, alongside strategies to enhance patient adherence. Bioactive compounds in Moringa, including flavonoids and phenolics, contribute to its antioxidant, anti-inflammatory, and antidiabetic effects. Novel techniques like lipid-based systems and microencapsulation improve bioavailability significantly. Clinical studies validate the efficacy of Moringa tablets in managing diabetes, cardiovascular diseases, and inflammation, though further research is needed to address gaps in standardization and long-term safety. Moringa oleifera tablets represent a promising intersection of traditional herbal medicine and modern pharmaceutical practices. Addressing current limitations through advanced technologies and interdisciplinary research will enable their integration into mainstream healthcare</span></p>